2009 Division Bibliography

Aistrup GL, Shiferaw Y, Kapur S, Kadish AH, Wasserstrom JA. Mechanisms underlying the formation and dynamics of subcellular calcium alternans in the intact rat heart. Circ Res. 2009;104:639-649. Aistrup GL, Villuendas R, Ng J, Gilchrist A, Lynch TW, Gordon D, Cokic I, Mottl S, Zhou R, Dean DA, Wasserstrom JA, Goldberger JJ, Kadish AH, Arora R. Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation. Cardiovasc Res. 2009;83:481-492.

 

Albert NM, Fonarow GC, Abraham WT, Gheorghiade M, Greenberg BH, Nunez E, O'Connor CM, Stough WG, Yancy CW, Young JB. Depression and clinical outcomes in heart failure: an OPTIMIZE-HF analysis. Am J Med. 2009;122:366-373.

 

Akhter N, Zhao Q, Rigolin V. Identification of prolapsing mitral valve scallops of myxomatous valve disease by novel 3-dimentional multiplanar reformation method. J Am Soc Echocardiogr. 2009;22:569.

 

Benjamin EJ, Chen P-S, Bild DE, Mascette AM, Albert CM, Alonso A, Calkins H, Connolly SJ, Curtis AB, Darbar D, Ellinor PT, Go AS, Goldschlager NF, Heckbert SR, Jalife J, Kerr CR, Levy D, Lloyd-Jones DM, Massie BM, Nattel S, Olgin JE, Packer DL, Po SS, Tsang TSM, Van Wagoner DR, Waldo AL, Wyse DG. Prevention of atrial fibrillation: report from a National Heart, Lung, and Blood Institute workshop. Circulation. 2009;119:606-618.

 

Berry JD, Lloyd-Jones DM. Traditional risk factors across short-, intermediate-, and long-term follow up in men and women. Cardiol Rev. 2009;26:30-34.

 

Berry JD, Liu K, Folsom AR, Lewis CE, Carr JJ, Polak J, Shea SJ, Sidney S, O’Leary DH, Chan C, Lloyd Jones DM. Prevalence and progression of subclinical atherosclerosis in younger adults with low short term but high lifetime estimated risk for cardiovascular disease: the Coronary Artery Risk Development in Young Adults Study and Multi-Ethnic Study of Atherosclerosis. Circulation. 2009; 119:382-389.

 

Betti I, Castelli G, Barchielli A, Beligni C, Boscherini V, De Luca L, Messeri G, Gheorghiade M, Maisel A, uppiroli A. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure: the PROBE-HF study. J Card Fail. 2009;15:377-384.

 

Blair JE, Khan S, Konstam MA, Swedberg K, Zannad F, Burnett JC Jr, Grinfeld L, Maggioni AP, Udelson JE, Zimmer CA, Ouyang J, Chen CF, Gheorghiade M; EVEREST Investigators. Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial. Eur Heart J. 2009;30:1666-1673.

 

Bonow RO. Should coronary calcium screening be used in cardiovascular prevention strategies? N Engl J Med. 2009;361: 990-997.

 

Brush JE, Rensing E, Cook S, Lynch J, Thacker L, Song F, Gurram S, Bonow RO, Brough J, Valentine M. A state-wide collaborative initiative to improve the quality of care for patients with acute myocardial infarction and heart failure. Circulation. 2009;119:1609-1615.

 

Budoff MJ, McClelland RL, Nasir K, Greenland P, Kronmal RA, Kondos GT, Shea S, Lima JA, Blumenthal RS. Cardiovascular events with absent or minimal coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J. 2009;158:554-561.

 

Burkhoff D. Parides M. Borggrefe M. Abraham WT. Kadish A. "Responder analysis" for assessing effectiveness of heart failure therapies based on measures of exercise tolerance. J Cardiac Fail.

2009;15:108-115.

 

Chandra S, Shah SJ, Thenappan T, Archer SL, Rich S, Gomberg-Maitland M. Carbon Monoxide Diffusing 

Capacity and Mortality in Pulmonary Arterial Hypertension. J Heart Lung Transplant. 2009 Sep 25. [Epub ahead of print] PubMed PMID: 19783169.

 

Chang H, Hassan A, Kim YL, Lloyd LJ, Koo BK, Ako J, Honda Y, Davidson CJ, Fitzgerald PJ. A novel technique for endovascular detection and removal of radiographic contrast during angiography. J Intervent Cardiol. 2009;21:314-318.

 

Chelu MG, Sarma S, Sood, S Wang S, van Oort RJ, Skapura DG, Li N, Santonastasi M, Muller FU, Schmitz W, Schotten U, Anderson ME, Valderrabano M, Dobrev D, Wehrens XH. Calmodulin kinase II mediated sarcoplasmic reticulum calcium leak promotes atrial fibrillation. J Clin Invest. 2009;119:1940-1951.

 

Chen W, Wasserstrom JA, Shiferaw Y. Role of coupled gating between cardiac ryanodine receptors in the genesis of triggered arrhythmias. Am J Physiol Heart Circ Physiol. 2009;297: H171-H180.

 

Chicos AB, Kannankeril PJ, Kadish AH, Goldberger JJ. Parasympathetic effects on cardiac electrophysiology during exercise and recovery in patients with left ventricular dysfunction. Am J Physiol Heart Circ Physiol. 2009;297: H743-H749.

 

Collins SP, Levy PD, Lindsell CJ, Pang PS, Storrow AB, Miller CD, Naftilan AJ, Thohan V, Abraham WT, Hiestand B, Filippatos G, Diercks DB, Hollander J, Nowak R, Peacock WF, Gheorghiade M. The rationale for an acute heart failure syndromes clinical trials network. J Card Fail. 2009;15:467-474.

 

Curtis AB, Yancy CW, Albert NM, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, Oconnor CM, Reynolds D, Walsh MN, Fonarow GC. Cardiac resynchronization therapy utilization for heart failure: findings from IMPROVE HF. Am Heart J. 2009;158:956-964.

 

Daubert JP. Winters SL. Subacius H. Berger RD. Ellenbogen KA. Taylor SG. Schaechter A. Howard A. Kadish A. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy. PACE. 2009;32:755-761.

 

Donlan SM, Quattromani E, Pang PS, Gheorghiade M. Therapy for acute heart failure syndromes. Curr Cardiol Rep. 2009;11:192-201.

 

Douglas PS, Taylor A, Bild D, Bonow RO, Greenland P, Lauer M, Peacock F, Udelson JE. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart Lung and Blood Institute. J Am Coll Cardiol Img 2009;2:897-907; Circulation Imaging 2009;2:339-348; J Am Soc Echocardiogr 2009;22:766-773; and J Cardiovasc Comput Tomogr 2009;3:2122-23.

 

Elhendy AA, Gregory SA, Holly TA, Vitola JV. Combined pharmacologic and low-level exercise stress protocols for radionuclide myocardial perfusion imaging. J Nucl Cardiol 2009;16:163.

 

Farmakis D. Filippatos G. Parissis J. Kremastinos DT. Gheorghiade M. Hyponatremia in heart failure. Heart Fail Rev. 2009;14:59-63.

 

Flaherty JD, Bax JJ, De Luca L, Rossi JS, Davidson CJ, Filippatos G, Liu PP, Konstam MA, Greenberg B, Mehra MR, Breithardt G, Pang PS, Young JB, Fonarow GC, Bonow RO,Gheorghiade M. Acute heart failure syndromes in patients with coronary artery disease early assessment and treatment. J Am Coll Cardiol. 2009;53:254-262.

 

Flaherty JD, Rossi JS, Fonarow GC, Nunez E, Stough WG, Abraham WT, Albert NM, Greenberg BH, O'Connor CM, Yancy CW, Young JB, Davidson CJ, Gheorghiade M. Influence of coronary angiography on the utilization of therapies in patients with acute heart failure syndromes: findings from Organized  Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF). Am Heart J. 2009;157:1018-1025.

 

Flynn KE, Piña IL, Whellan DJ, Lin L, Blumenthal JA, Ellis SJ, Fine LJ, Howlett JG, Keteyian SJ, Kitzman DW, Kraus WE, Miller NH, Schulman KA, Spertus JA, O'Connor CM, Weinfurt KP. Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA. 2009;301:1451-1459.

 

Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol. 2009;104:107-115.

 

Fuster V, van der Zee S, Elmariah S, Bonow RO. Academic careers in cardiovascular medicine. Circulation. 2009;119: 754-760.

 

Gheorghiade M, Adams KF, Cleland JG, Cotter G, Felker GM, Filippatos GS, Fonarow GC, Greenberg BH, Hernandez AF, Khan S, Komajda M, Konstam MA, Liu PP, Maggioni AP, Massie BM, McMurray JJ, Mehra M, Metra M, O'Connell J, O'Connor CM, Pang PS, Piña IL, Sabbah HN, Teerlink JR, Udelson JE, Yancy CW, Zannad F, Stockbridge N. Phase III clinical trial end points in acute heart failure syndromes: a virtual roundtable with the Acute Heart Failure Syndromes International Working Group. Am Heart J. 2009;157:957-970.

 

Gheorghiade M. Braunwald E. Reconsidering the role for digoxin in the management of acute heart failure syndromes. JAMA. 2009;302:2146-2147.

 

Gheorghiade M, Harinstein ME, Filippatos GS. Digoxin for the treatment of chronic and acute heart failure syndromes. Acute Card Care. 2009;11:83-87.

 

Gheorghiade M, Khan S, Blair JE, Harinstein ME, Krum H, Mukherjee R, Pitt B. The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction. Am Heart J. 2009;158:437-443.

 

Gheorghiade M, Pang PS. Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol. 2009;53:2349-2352.

 

Gheorghiade M, Pang PS. Acute heart failure syndromes. J Am Coll Cardiol. 2009;53:557-573.

 

Gheorghiade M, Pang PS. Are BNP changes during hospitalization for heart failure a reliable surrogate for predicting the effects of therapies on post-discharge mortality? J Am Coll Cardiol. 2009;53:2349-2352.

 

Goff DC Jr, Greenland P. The change we need in health care. Arch Intern Med. 2009;169:737-739.

 

Gold MR, Niazi I, Giudici M, Leman RB, Sturdivant JL, Kim MH, Waggoner AD, Ding J, Arcot-Krishnamurthy S, Daum D, Yu Y. Acute hemodynamic effects of atrial pacing with cardiac resychronization therapy. J Cardiovasc Electrophysiol. 2009;20:894-900.

 

Goldberger JJ. Evidence-based analysis of risk factors for sudden cardiac death. Heart Rhythm. 2009;6:S2-7.

 

Goldberger JJ, Passman R. Implantable cardioverter defibrill-ator therapy after acute myocardial infarction: The results are not shocking. J Am Coll Cardiol. 2009;54:2001-2005.

 

Gordon D, Kadish AH, Koolish D, Taneja T, Ulphani J, Goldberger JJ, Ng J. High resolution electrical mapping of depolarization and repolarization alternans in an ischemic dog model. Am J Physiol Heart Circ Physiol. 2009 Nov. [Epub ahead of print] PMID: 19915171

 

Greenland P. Time for the medical profession to act: new policies needed now on interactions between pharmaceutical companies and physicians.Arch Intern Med.2009;169:829-831.

 

Greenstein E, Frazin LJ. A fellow's perspective on handheld echo during cardiology rounds: "Me and Charlie down by the bedside." Echocardiography. 2009;26:742-743.

 

Gupta R, Tongers J, Losordo DW. Human studies of angiogenic gene therapy. Circ Res. 2009;105:724-736.

 

Gulati M, Cooper-DeHoff R, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF; Arnsdorf MF, Black HR, Pepine CJ, Bairey Merz CN. Adverse cardiovascular outcomes In women with nonobstructive coronary artery disease: a report from the National Institutes of Health-National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Project. Arch Intern Med. 2009;169:843-850.

 

Hampole CV, Mehrotra AK, Thenappan T, Gomberg-Maitland M, Shah SJ. Usefulness of red cell distribution width as a prognostic marker in pulmonary hypertension.  Am J Cardiol. 2009;104:868-872.

 

Harinstein ME, Filippatos GS, Gheorghiade M. Acute heart failure syndromes: epidemiology, risk stratification and prognostic factors. Acute Card Care. 2009;11:77-82.

 

Harinstein ME, Filippatos GS, Gheorghiade M. Acute heart failure syndromes: the role of vasopressin antagonists. Acute Card Care. 2009;11:61-65.

 

Helber I, Dos Santos AA, Antonio EL, Flumignan RL, Bocalini DS, Piccolo C,Gheorghiade M, Tucci PJ. Digitoxin prolongs survival of female rats with heartfailure due to large myocardial infarction. J Card Fail. 2009;15:798-804.

 

Hlatky MA, Greenland P, Arnett DK, Ballantyne CM, Criqui MH, Elkind MS, Go AS, Harrell FE Jr, Hong Y, Howard BV, Howard VJ, Hsue PY, Kramer CM, McConnell JP, Normand SL, O'Donnell CJ, Smith SC Jr, Wilson PW. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408-2416.

 

Huang CC, Fornage M, Lloyd-Jones DM, Wei GS, Boerwinkle E, Liu K. Longitudinal association of PCSK9 sequence variations with low-density lipoprotein cholesterol levels: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Circ Cardiovasc Genetics. 2009;2: 354-361.

 

Huffman MD, Bonow RO. Clinical practice guidelines and scientific evidence. JAMA. 2009; 302:144-145

 

Huffman MD, Kaufman SR, Saint S. A new approach to resident morning report: introducing “VAVUM”. Intern Emerg Med. 2010;5:81-82.

 

Ilkhanoff L, Goldberger JJ. Recurrent atrial fibrillation after ablation: How ... Shocking. J Cardiovasc Electrophysiol. 2009;20:37-38.

 

Jefic D, Joel B, Good E, Morady F, Rosman H, Knight BP, Bogun F. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry. Heart Rhythm. 2009;6:189-195.

 

Jones DW, Peterson ED, Bonow RO, Bufalino V, Franklin B, Gardner T, Sacco R, Redberg R, Meltzer N, Solis P, Girgus M, Hinton P, Leonard A, Gibbons RJ. Partnering with patients to reduce risks and improve cardiovascular outcomes: American Heart Association initiatives in action. Circulation. 2009:119: 340-350.

 

Kadish AH, Bello D, Finn P, Bonow RO, Schaechter A, Subacius H, Albert C, Dauberrt J, Goldberger JJ. Defibrillators to Reduce Risk by Magnetic Resonance Imaging (DETER-MINE). J Cardiovasc Electrophysiol. 2009;20:982–987.

 

Kadish AH. Rubenstein JC. Connecting the dots: the relevance of scar in nonischemic cardiomyopathy. J Am Coll Cardiol. 2009;53:1146-1147.

 

Kapur S, Wasserstrom JA, Kelly JE, Kadish AH, Aistrup GL. Acidosis and ischemia increase intracellular Ca2+- and repolarization alternans susceptibility in the intact rat heart. Am J Physiol Heart Circ Physiol. 2009;296:H1491-H1512.

 

Khan H, Metra M, Blair JE, Vogel M, Harinstein ME, Filippatos GS, Sabbah HN, Porchet H, Valentini G,

Gheorghiade M. Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes? Heart Fail Rev. 2009;14:277-287.

 

Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J. The scientific foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop. Genet Med. 2009;11: 559-567.

 

Kim HW, Klem I, Shah DJ, Wu, E, Meyers SN, Parker MA, Crowley AL, Bonow RO, Judd RM, Lim RJ. Unrecognized non-Q-wave myocardial infarction: prevalence and prognostic significance in patients

with suspected coronary artery disease. PLOS Medicine. 2009;6:e100000057.doi:10.1371/journal.

pmed.1000057

 

Kim MH, Klingman D, Lin J, Pathak P, Battleman D. Cost of hospital admission for antiarrhythmic drug initiation in atrial fibrillation. Ann Pharmacother. 2009;43:840-848.

 

Kim MH, Klingman D. Lin J, Battleman DS. Patterns and predictors of discontinuation of rhythm-control therapy in patients with newly diagnosed atrial fibrillation. Pharmacother. 2009;29:1417-1426.

 

Kim MH, Lin J, Hussein M, Battleman D. Incidence and temporal pattern of hospital readmissions for patients with atrial fibrillation. Curr Med Res Opin. 2009;25:1215-1220.

 

Kim MH, Lin J, Hussein M, Kreilick C, Battleman D. Cost of atrial fibrillation in United States managed care organizations. Adv Ther. 2009;26:847-857.

 

Kim MH, Lin J, Hussein M, Battleman D. The incidence and economic burden of suspected adverse events and adverse event monitoring during atrial fibrillation therapy. Curr Med Res Opin. 2009;25:3037-3047.

 

Kim MH, Lin J, Kreilick C. National assessment of Medicare prescription plan coverage gaps among patients with atrial fibrillation in the US. Adv Ther. 2009;26:784-794.

 

Kim MK, McGarry TJ, O’Broin P, Flatow JM, Golden AA, Licht JD.  An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1. Proc Natl Acad Sci USA. 2009;106:11154-11159.

 

Kim SS, Hijazi Z, Lang RL, Knight BP. The use of intracardiac echocardiography and other intracardiac imaging tools to guide interventional cardiac procedures. J Am Coll Cardiol. 2009;53:2117-2128.

 

Klocke FJ. Emerging applications of T2-weighted cardiac magnetic resonance imaging in acute ischemic syndromes. J Am Coll Cardiol. 2009;53:1202-1203.

 

Klocke FJ. Ranolazine and the myocardial demand-supply balance. J Am Coll Cardiol Img. 2009;2:1310-1312.

 

Knight BP. Transesophageal echocardiography before atrial fibrillation ablation: looking before cooking. J Am Coll Cardiol. 2009;54:2040-2042.

 

Laskey W, Aspelin P, Davidson CJ, Rudnick M, Aubry P, Kumar S, Gletzen F, Wiemer M. Nephrotoxicity of iodixanol versus iopamidol in patients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures. Am Heart J. 2009;158:822-828.

 

Lee DC, Johnson NP. Quantification of absolute myocardial blood flow by magnetic resonance perfusion imaging. J Am Coll Cardiol Img. 2009;2:761-770.

 

Levin MD, Lu MM, Petrenko NB, Hawkins BJ, Gupta TH, Lang D, Buckley PT, Jochems J, Liu F, Spurney CF, Yuan LJ, Jacobson JT, Brown CB, Huang L, Beermann F, Margulies KB, Madesh M, Eberwine JH, Epstein JA, Patel VV. Melanocyte-like cells in the heart and pulmonary veins contribute to atrial arrhythmia triggers. J Clin Invest. 2009; 119:3420-3436.

 

Lim KK, Maron BJ, Knight BP. Successful catheter ablation of hemodynamically unstable monomorphic ventricular tachycardia in a patient with hypertrophic cardiomyopathy and apical aneurysm. J Cardiovasc Electrophysiol. 2009;20:445-447.

 

Lim KK, Reddy S, Desai S, Kessler E, Khunnawat C, Smelley M, Kim SS, Beshai J, Lin AC, Burke MC, Knight BP. Effects of electrocautery on transvenous lead insulation materials. J Cardiovasc Electrophysiol. 2009;20:429-435.

 

Lloyd-Jones DM. Clinical trials report. Curr Cardiovasc Risk Rep. 2009;3:233-234.

 

Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, teinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics--2009 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.Circulation. 2009;119:e21-e181.

 

Lloyd-Jones D, Haase N, Hong Y. Heart disease and stroke statistics--2009 update, executive summary. Circulation. 2009;119:480-486.

 

Lloyd-Jones DM, Walsh JA, Prineas RJ, Ning H, Liu K, Daviglus ML, Shea S, Detrano RC, Tandri H, Greenland P. Association of electrocardiographic abnormalities with coronary artery calcium and carotid intimal-medial thickness in individuals without clinical evidence of coronary heart disease: from the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Cardiol. 2009;104:1086-1091. Lynch E, Liu K, Wei GS, Spring B, Kiefe C, Greenland P. The relation between body size perception and change in body mass index over 13 years: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Epidemiol. 2009;169:857-866.

 

Marma AK, Lloyd-Jones DM. Systematic examination of the updated Framingham Heart Study general cardiovascular risk profile. Circulation. 2009;120:384-390.

 

Matthew P. Smelley MP, Shah DP, Weisberg I, Kim SS, Lin AC, Beshai JF, Burke MC, Knight BP. Initial experience using a powered radiofrequency transseptal needle. J Cardiovasc Electrophysiol. 2009;20:689-91.

 

Mathur N, Sood S, Wang S, van Oort RJ, Sarma S,Li N, Skapura DG, Bayle JH, Valderrabano M, Wehrens XH. Sudden infant death syndrome in mice with an inherited mutation in RyR2. Circ Arrhythm Electrophysiol. 2009;2:677-685.

 

McDermott MM, Ades P, Guralnik JM, Dyer A, Ferrucci L, Liu K, Nelson M, Lloyd-Jones D, Van Horn L, Garside D, Kibbe M, Domanchuk K, Stein JH, Liao Y, Tao H, Green D, Pearce WH, Schneider JR, McPherson D, Laing ST, McCarthy WJ, Shroff A, Criqui MH. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA. 2009; 301:165-174.

 

McDermott MM, Lloyd-Jones DM. The role of biomarkers and genetics in peripheral arterial disease. J Am Coll Cardiol. 2009;54:1228-1237.

 

McGarry TJ, Bonaguidi M, Lyass L, Kessler J, A., Bodily JM, Doglio L. Enucleation of feeder cells and egg cells with psoralens.  Develop Dynamics. 2009;238:2614-2621.

 

Mebazaa A, Pang PS, Tavares M, Collins SP, Storrow AB, Laribi S, Andre S, Courtney DM, Hasa J, Spinar J, Masip J, Peacock WF, Sliwa K, Gayat E, Filippatos G, Cleland JG, Gheorghiade M. The impact of early standard therapy on dyspnoea in patients with acute heart failure: the URGENT-dyspnoea study. Eur Heart J. 2009;Nov 11. [Epub ahead of print] PubMed PMID: 19906690.

 

Mehra MR, Yancy CW, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, O'Connor CM, Reynolds D, Walsh MN, Fonarow GC. Evidence of clinical practice heterogeneity in the use of implantable cardioverter-defibrillators in heart failure and post-myocardial infarction left ventricular dysfunction: Findings from IMPROVE HF. Heart Rhythm. 2009;6:1727-1734.

 

Michos ED, Rice KM, Szklo M, Burke GL, Siscovick DS, Tracy RP, Graham Barr R, Nettleton JA, Greenland P, Jacobs DR Jr, Post W. Factors associated with low levels of subclinical vascular disease in older adults: multi-ethnic study of atherosclerosis. Prev Cardiol. 2009;12:72-79.

 

Mitrovic V, Hernandez AF, Meyer M, Gheorghiade M. Role of guanylate cyclase modulators in decompensated heart failure. Heart Fail Rev. 2009;14:309-319.

 

Mosley WJ, Lloyd-Jones DM. Epidemiology of hypertension in the elderly. Clin Geriatric Med. 2009;25:179-189.

 

Ng J, Sundaram S, Kadish AH, Goldberger JJ. Autonomic effects on the spectral analysis of heart rate variability after exercise. Am J Physiol 2009;297:H1421-428.

 

Ogunyankin KO. Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure. Circulation. 2009;120;e45.

 

Ogunyankin KO, Andrew G Day. Successful treatment of hypertension accounts for improvements in markers of diastolic function- a pilot study comparing hydrochlorthiazide-based and amlodipine-based treatment strategies. Can J Cardiol. 2009;25:e406-e412.

 

Pang JH, Kim D, Beohar N, Meyres, SN, Lloyd-Jones D, Yaghmai V. Detection of stent fractures: a comparison of 64-slice CT, conventional cine-angiography, and intravascular ultrasonogrpahy. Academ Radiol 2009;16:412-417.

 

Pang PS, Gheorghiade M. Special cases in acute heart failure syndromes: atrial fibrillation and wide complex tachycardia. Heart Failure Clin. 2009;5:113-123.

 

Pang PS, Konstam MA, Krasa HB, Swedberg K, Zannad F, Blair JE, Zimmer C, Teerlink JR, Maggioni AP,  Burnett JC Jr, Grinfeld L, Ouyang J, Udelson JE, Gheorghiade M. Effects of tolvaptan on dyspnoea relief from the EVEREST trials. Eur Heart J. 2009;30:2233-2240.

 

Park DW, Flaherty JD, Davidson CJ, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ. Prognostic influence of diabetes mellitus on long-term clinical outcomes and stent thrombosis after drug-eluting stent implantation in Asian patients. Am J Cardiol. 2009;103:646-652.

 

Passman R, Banthia S, Galvez D, Sheldon T, Kadish A.The effects of rate-adaptive atrial pacing versus ventricular backup pacing on exercise capacity in patients with left ventricular dysfunction. PACE. 2009;32:1-6.

 

Passman R,Goldberger J. ICDs post-myocardial infarction: the results aren’t shocking. J Am Coll Cardiol. 2009;54: 2001-2005.

 

Passman R, Kadish A. Shouldn’t everyone have an implantable cardioverter-defibrillator? Circulation. 2009; 120:2166-2167.

 

Passman R, Sears S, Kadish A. Defibrillators in heart failure and quality of life (Letter). N Engl J Med. 2009;360: 187-189.

 

Payvandi L, Dyer A, McPherson D, Ades P, Stein J, Liu K, Ferrucci L, Criqui MH, Guralnik JM, Lloyd-Jones D, Kibbe MR, Liang ST, Kane B, Pearce WH, Verta M, McCarthy WJ, Schneider JR, Shroff A, McDermott MM. Physical activity during daily life and brachial artery flow-mediated dilation in peripheral arterial disease. Vasc Med. 2009;14: 193-201.

 

Peacock WF, Fonarow GC, Ander DS, Collins SP, Gheorghiade M, Kirk JD, Filippatos G, Diercks DB, Trupp RJ, Hiestand B, Amsterdam EA, Abraham WT, Amsterdam EA, Dodge G, Gaieski DF, Gurney D, Hayes CO, Hollander JE, Holmes K, Januzzi JL Jr, Levy P, Maisel A, Miller CD, Pang PS, Selby E, Storrow AB, Weintraub NL, Yancy CW, Bahr RD, Blomkalns AL, McCord J, Nowak RM, Stomel RJ..Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient-parts 1-6. Acute Card Care. 2009;11:3-42.

 

Perk G, Lodato J, Lang RM, Garcia-Fernandez MA, Sugeng L, Lopez J, Knight BP, Shah S, Hijazi Z, Slater J, Varkey M, Kronzon I. Use of real time three dimensional trans-esophageal echocardiography in intracardiac trans-catheter interventions. J Am Soc Echocardiogr.2009;22: 865-882.

 

Persell SD, Dunne AP, Lloyd-Jones DM, Baker DW. Electronic health record-based cardiac risk assessment and identification of unmet preventive needs. Medical Care. 2009;47:418-424.

 

Picano E, Pibarot P, Lancellotti P, Monin JL, Bonow RO.The emerging role of exercise testing and stress echocardiography in valvular heart disease. J Am Coll Cardiol. 2009;54:2251-2260.

 

Pitt B, Zannad F, Gheorghiade M, Martínez F, Love TE, Daniel C, Ahmed A. Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: A ropensity-matched study of the EPHESUS trial. Int J Cardiol. 2009 Apr 14. [Epub ahead of print] PubMed PMID: 19371959.

 

Redberg RF, Benjamin EJ, Bittner V, Braun LT, Goff DC Jr, Havas S, Labarthe DR, Limacher MC, Lloyd-Jones DM, Mora S, Pearson TA, Radford MJ, Smetana GW, Spertus JA, Swegler EW. ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults. J Am Coll Cardiol. 2009;54:364-1405;Circulation. 2009;120: 1296-1336.

 

Reiter MJ, Harsch M, Lung T, Munneke D, Kim MH, Shalaby A. Influence of structural heart disease on charac-teristics of atrial fibrillation recurrence in patients with dual chamber pacemakers.

J Electrocardiology.2009;42:128-135.

 

Rubenstein JC, Kim MH, Jacobson JT. A novel method for sinus node modification and phrenic nerve protection in re-sistant cases.J Cardiovasc Electrophysiol. 2009;20:689-691.

 

Russell RR, Abbott BG, Arrighi JA, Bengel FM, Case JA, Faber TL, Holly TA, Mieres JH, Miller TD, Shaw LJ, Wackers FJ, Bax JJ. Highlights of the 2008 Scientific Sessions of the American Society of Nuclear Cardiology: Boston, Massachusetts, September 10-14, 2008. J Nucl Cardiol. 2009;16:440-446.

 

Russo RJ, Silva P, Teirstein PS, Attubato MJ, Davidson CJ, DeFranco AC, Fitzgerald PJ, Goldberg SL, Hermiller JB, Leon MB, Ling FS, Lucisano JE, Schatz RA, Wong SC, Weissman NJ, Zientek DM. A randomized controlled trial of Angioplasty Versus Intravascular Ultrasound-Directed bare-metal coronary stent placement (The AVID Trial). Circ Cardiovasc Intervent. 2009;2:113-123.

 

Sauer WH, Jacobson JT, Paradoxical slowing of orthodromic reciprocating tachycardia with loss of bundle branch block ipsilateral to the accessory pathway. J Cardiovasc Electrophysiol. 2009;20:347-348.

 

Schliamser JE, Saleem MA, Goldberger JJ.  Use of a custom-designed adapter to manage ICD lead fracture. J Cardiovasc Electrophysiol. 2009;20:1284-1286.

 

Shah DP, Knight BP. Transseptal Catheterization Using a Powered Radiofrequency Transseptal Needle. A Case Report.  J Interven Cardiac Electrophysiology. Epub ahead of print, June 16, 2009.

 

Shah RU, Klein L, Lloyd-Jones DM. Heart failure in women: epidemiology, biology and treatment. Womens Health (London). 2009;5:517-527.

  

Shah SJ. Genetics of systemic sclerosis-associated pulmonary arterial hypertension: recent progress and current concepts. Curr Rheumatol Rep. 2009;11:89-96.

 

Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, Bubenek-Turconi SI, Ceracchi M, Bianchetti M, Carminati P, Kremastinos D, Grzybowski J, Valentini G, Sabbah HN, Gheorghiade M. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neuro-hormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial. Am Heart J. 2009;157:1035-1041.

 

Shah SJ, Gomberg-Maitland M, Thenappan T, Rich S. Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. Chest. 2009;136:694-700.

 

Shah SJ, Thenappan T, Rich S, Sur J, Archer SL, Gomberg-Maitland M. Value of exercise treadmill testing in the risk stratification of patients with pulmonary  hypertension. Circ Heart Fail. 2009;2:278-286.

 

Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EAM, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. The Role of intensive glycemic control in the prevention of cardiovascular disease: implications of the ACCORD, ADVANCE, and VADT studies. Diabetes Care 2009;32:187-192; Circulation. 2009: 119:351-357; J Am Coll Cardiol. 2009;53:298-304.

 

Smelley MP, Knight BP. Approaches to ablation of persistent atrial fibrillation. Heart Rhythm. 2009;6 (Suppl): S33-38.

 

Sridharan L, Greenland P. Editorial policies and publication bias: the importance of negative studies. Arch Intern Med. 2009;169:1022-1023.

 

Soukoulis V, Dihu JB, Sole M, Anker SD, Cleland J, Fonarow GC, Metra M, Pasini E, Strzelczyk T, Taegtmeyer H, Gheorghiade M. Micronutrient deficiencies: an unmet need in heart failure. J Am Coll Cardiol.  2009;54:1660-1673.

 

Tempelhof M. Comparative role of angiotensin receptor blockers versus other agents in the management of hypertension, cardiovascular disease and nephropathy. South Med J. 2009;102:1201-1202.

 

Tempelhof M. Personal digital assistants: a review of current and potential utilization among residents.

Teach Learn Med. 2009;21:100-104.

 

Tempelhof M, Garman KS, Langman MK, Adams MB. Leveraging time and learning style, iPod vs realtime attend-ance at a series of medicine residents conferences: a rando-mised controlled trial. Inform Prim Care. 2009;17:87-94.

 

Tempelhof M, Gray AL, Wallace TW. An interesting case of positional hypoxia: the effect of multiple synergistic pathological conditions. South Med J. 2009;102:211-213.

 

Tempelhof M, Wang T. Use of clinical risk stratification systems among patients with acute coronary syndrome. Acute Cor Synd J. 2009;102:230-238. 

 

Teerlink JR, Metra M, Zacà V, Sabbah HN, Cotter G, Gheorghiade M, Cas LD. Agents with inotropic properties for the management of acute heart failure syndromes: tradi-tional agents and beyond. Heart Fail Rev. 2009;14:243-253.

 

Thenappan T, Shah SJ, Rich S, Tian L, Archer SL, Gomberg-Maitland M. Contemporary survival in patients with pulmonary arterial hypertension: a Reappraisal of the National Institutes of Health Risk Stratification Equation. Eur Respir J. 2009 [Epub ahead of print, Dec 23] PubMed PMID: 20032020.

 

Thomas J, Zoghbi WA, Beller GA, Bonow RO, Budoff MJ, Cerqueira M, Creager MA, Douglas PS, Garcia MJ, Holmes DR, Manning WJ, Pohost GM, Ryan TJ, Van Decker WA, Wiegers SE. ACCF training statement on multimodality non-invasive cardiovascular imaging. a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. J Am Coll Cardiol. 2009;53:125-146.

 

Wang GS, Kuyumcu-Martinez MN, Sarma S, Mathur N, Wehrens XH, Cooper TA. PKC inhibition by Ro-31-8220 ameliorates the cardiac phenotype of a mouse model for myotonic dystrophy, type 1. J Clin Invest. 2009;119:3797-3806.

 

Wasserstrom JA, Sharma R, Kapur S, Kelly JE, Kadish AH, Balke CW, Aistrup GL. Multiple defects in intracellular calcium cycling in intact failing rat heart. Circ Heart Fail. 2009;2:223-232.

 

Wasserstrom JA, Sharma R, O’Toole MJ, Zheng J, Kelly J, Shryock JC, Belardinelli L, Aistrup GL. Ranolazine antagonizes the effects of increased late sodium current on intracellular calcium cycling in rat isolated intact heart. J Pharmacol Exp Ther. 2009;331:382-391.

 

Weinsaft JW, Kim RJ, Ross M, Krauser D, Manoushagian S, LaBounty TM, Cham MD, Min JK, Healy K, Wang Y, Parker M, Roman MJ, Devereux RB.  Contrast-enhanced anatomical imaging as compared to contrast-enhanced tissue characterization for detection of left ventricular thrombus.  J Am Coll Cardiol Img 2009;2:969-979.

 

Wickramasinghe SR, DeFillippis AP, Lloyd-Jones DM, Blumenthal RS. A convenient tool to profile patients for generalized cardiovascular disease risk in primary care. Am J Cardiol. 2009;103:1174-1177.

 

Wilkins J, Lloyd-Jones DM. Short-term and lifetime risk estimation for cardiovascular disease. Curr Cardiovasc Risk Rep. 2009;3:144-149.

 

Wood AM, Greenland P. Evaluating the prognostic value of new cardiovascular biomarkers. Dis Markers. 2009;26:199-207.

 

Wu Y, Gao Z, Chen B, Koval OM, Singh MV, Guan X, Hund TJ, Kutschke W, Sarma S, Grumbach IM, Wehrens XH, Mohler PJ, Song LS, Anderson ME. Calmodulin kinase II is required for fight or flight sinoatrial node physiology. Proc Natl Acad Sci USA. 2009;106:5972-5977.

 

Yancy CW, Fonarow GC, Albert NM, Curtis AB, Stough WG, Gheorghiade M, Heywood JT, McBride ML, Mehra MR, O'Connor CM, Reynolds D, Walsh MN. Influence of patient age and sex on delivery of guideline-recommended heart failure care in the outpatient cardiology practice setting: findings from IMPROVE HF. Am Heart J. 2009; 157:754-762.

 

Zheng L. Yao Y. Zhang S. Chen W. Zhang K. Wang F. Chen X. He DS. Kadish AH. Organized left atrial tachyarrhythmia during stepwise linear ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20:499-506.